The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells

被引:20
|
作者
Odum, N
Bregenholt, S
Eriksen, KW
Skov, S
Ryder, LP
Bendtzen, K
Van Neerven, RJJ
Svejgaard, A
Garred, P
机构
[1] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Cell Cybernet Lab, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark
[3] Natl Hosp, Tissue Typing Lab, Copenhagen, Denmark
[4] Univ Copenhagen, Natl Hosp, Inst Inflammat Res, Copenhagen, Denmark
[5] ALK ABELLO Grp, Horsholm, Denmark
来源
TISSUE ANTIGENS | 1999年 / 54卷 / 06期
关键词
CCR5; Th1; cytokines;
D O I
10.1034/j.1399-0039.1999.540606.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The CC-chemokine receptor 5 (CCR5) has recently been described as a surface marker of human T cells producing type 1 (Th1) cyto- kines. Here we confirm that CCR5 is expressed on human Th1 but not on Th2 T-cell clones. Using intracellular cytokine staining, we show that alloantigen specific CD4(+) T-cell lines derived from a CCR5-deficient. individual (Delta 32 allele homozygote) contain high numbers of both interferon gamma (IFN-gamma) and interleukin (IL)-2 producing cells, low numbers of IL-10 producing cells and no IL-4 or IL-5 producing cells when stimulated with phorbol ester and ionomycin in vitro. These results were similar to those obtained from allo-antigen specific CD4(+) T-cell lines derived from CCR5 expressing individuals An enzyme-linked immunoabsorbent assay (ELISA) confirmed that the Th1 cytokine-positive cells from the CCR5-deficient individual were able to produce equal amounts of cytokines when compared to T-cell lines from CCR5-expressing individuals These results demonstrate that CCR5-negative T cells display the same capacity of Th1 T-cell differentiation as T cells derived h-om CCR5-expressing individuals Thus, CCR5 expression is not essential for differentiation of human Th1 T cells.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 50 条
  • [21] Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women
    Figen Gurdol
    Leman M. Yurdum
    Ummühan Ozturk
    Elif Isbilen
    Bedia Cakmakoglu
    Archives of Gynecology and Obstetrics, 2012, 286 : 51 - 54
  • [22] Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women
    Gurdol, Figen
    Yurdum, Leman M.
    Ozturk, Ummuhan
    Isbilen, Elif
    Cakmakoglu, Bedia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (01) : 51 - 54
  • [23] Biological consequences of chemokine receptor polarization on TH1 and TH2 cells from individuals wild-type for CCR5 or homozygous for the Δ32 CCR5 allele.
    Lee, B
    Bailer, RT
    Rucker, J
    Tsang, M
    Doms, RW
    Montaner, LJ
    BLOOD, 1998, 92 (10) : 21A - 21A
  • [24] CCR5 is characteristic of Th1 lymphocytes
    Loetscher, P
    Uguccioni, M
    Bordoli, L
    Baggiolini, M
    Moser, B
    NATURE, 1998, 391 (6665) : 344 - 345
  • [25] Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines
    Margolis, LB
    Glushakova, S
    Grivel, JC
    Murphy, PM
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09): : 1876 - 1880
  • [26] Distribution of human chemokine (C-X3-C) receptor 1 (CX3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression
    Li, C
    Lu, SC
    Hsieh, PS
    Huang, YH
    Huang, HI
    Ying, TH
    Shieh, B
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2005, 32 (02) : 99 - 106
  • [27] Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7
    Steen, Anne
    Thiele, Stefanie
    Guo, Dong
    Hansen, Laerke S.
    Frimurer, Thomas M.
    Rosenkilde, Mette M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (18) : 12511 - 12521
  • [28] Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-Chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro
    Maeda, K
    Nakata, H
    Koh, Y
    Miyakawa, T
    Ogata, H
    Takaoka, Y
    Shibayama, S
    Sagawa, K
    Fukushima, D
    Moravek, J
    Koyanagi, Y
    Mitsuya, H
    JOURNAL OF VIROLOGY, 2004, 78 (16) : 8654 - 8662
  • [29] Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach
    Thiele, Stefanie
    Steen, Anne
    Jensen, Pia C.
    Mokrosinski, Jacek
    Frimurer, Thomas M.
    Rosenkilde, Mette M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (43) : 37543 - 37554
  • [30] Analysis of the CC chemokine receptor 5 (CCR5) Δ32 polymorphism in Behcet's disease
    Yang, X
    Ahmad, T
    Gogus, F
    Wallace, GR
    Madanat, W
    Kanawati, CA
    Stanford, MR
    Fortune, F
    Jewell, DP
    Marshall, SE
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2004, 31 (01): : 11 - 14